WallStSmart

McCormick & Company Incorporated (MKC)vsUSANA Health Sciences Inc (USNA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

McCormick & Company Incorporated generates 709% more annual revenue ($7.39B vs $913.36M). MKC leads profitability with a 21.9% profit margin vs -2.4%. USNA appears more attractively valued with a PEG of 0.68. MKC earns a higher WallStSmart Score of 67/100 (B-).

MKC

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 7.5Value: 7.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.58

USNA

Hold

44

out of 100

Grade: D

Growth: 2.0Profit: 3.5Value: 6.0Quality: 7.3
Piotroski: 4/9Altman Z: 4.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKCUndervalued (+26.7%)

Margin of Safety

+26.7%

Fair Value

$96.17

Current Price

$51.32

$44.85 discount

UndervaluedFair: $96.17Overvalued

Intrinsic value data unavailable for USNA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKC5 strengths · Avg: 8.8/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Return on EquityProfitability
23.3%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
21.9%9/10

Keeps 22 of every $100 in revenue as profit

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

USNA3 strengths · Avg: 9.3/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
4.8210/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.688/10

Growing faster than its price suggests

Areas to Watch

MKC3 concerns · Avg: 3.3/10
PEG RatioValuation
2.024/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.584/10

Distress zone — elevated risk

EPS GrowthGrowth
-14.2%2/10

Earnings declined 14.2%

USNA4 concerns · Avg: 2.5/10
Market CapQuality
$276.41M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.1%3/10

Operating margin of 4.1%

Return on EquityProfitability
-4.1%2/10

ROE of -4.1% — below average capital efficiency

Revenue GrowthGrowth
-5.3%2/10

Revenue declined 5.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : MKC

The strongest argument for MKC centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 21.9% and operating margin at 17.4%. Revenue growth of 16.7% demonstrates continued momentum.

Bull Case : USNA

The strongest argument for USNA centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.68 suggests the stock is reasonably priced for its growth.

Bear Case : MKC

The primary concerns for MKC are PEG Ratio, Altman Z-Score, EPS Growth.

Bear Case : USNA

The primary concerns for USNA are Market Cap, Operating Margin, Return on Equity.

Key Dynamics to Monitor

MKC profiles as a growth stock while USNA is a turnaround play — different risk/reward profiles.

USNA carries more volatility with a beta of 0.68 — expect wider price swings.

MKC is growing revenue faster at 16.7% — sustainability is the question.

MKC generates stronger free cash flow (337M), providing more financial flexibility.

Bottom Line

MKC scores higher overall (67/100 vs 44/100), backed by strong 21.9% margins and 16.7% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

McCormick & Company Incorporated

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

USANA Health Sciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Want to dig deeper into these stocks?